NetworkNewsBreaks Archive - Page 156 of 1741

MondayJul 31, 2023 1:01 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) ‘Buy’ Rating Maintained, WestPark Capital Increases Price Target

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services was spotlighted in a recent WestPark Capital Technology research report. On July 21st, WestPark Capital, a full-service investment banking and securities brokerage firm, adjusted its D-Wave FY23 revenue/EPS estimates to $12.0 million, maintained FY24 revenue/EPS estimates of $27 million, re-iterated its buy rating on QBTS, and increased their 12-month price target by 100% from $3 to $6. WestPark Capital’s Kevin Garrigan stated “We believe D-Wave's quantum annealing system provides benefits and cost savings to commercial customers,” the report analysis stated. “Being the only company that has built…

MondayJul 31, 2023 10:29 am

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Releases Status Update on Financing Efforts

GEMXX Corporation (OTC: GEMZ) is making progress in financing its gold and Ammolite mining operations. According do a recent announcement, the company has developed relationships with new investors and partners that strengthen its financial position and support its growth plan. The company’s Form 1-A to raise up to $6 million is fully qualified, and shareholders, investors, institutions, and financiers interested in participating in the Regulation A financing can visit the company website for more information. In addition, GEMXX announced that it has come up with a short list of engineering firms capable of conducting National Instrument 43-101 reports on both its gold and…

FridayJul 28, 2023 3:10 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces ASR Deployment to Vancouver Hotel, Next Stop in Robot Roadshow

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has deployed another K5 ASR; the robot was sent to a hotel in Vancouver, Washington. The new deployment is the latest in a growing number of deployments as Knightscope continues its momentum in providing safety and security in a wide array of spaces. The impact that KSCP ASRs have on hotel security is becoming increasingly recognized. “Modern security systems, like the one deployed by Knightscope here, are conspicuous, engaging and enjoyable for guests, while providing a natural deterrence to poor decisions that may lead…

FridayJul 28, 2023 1:25 pm

NetworkNewsBreaks — Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Preparing to Meet Surging Graphite Demand as World Shifts to Electrification

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2), a strategic minerals company, is actively exploring its Ruby Graphite Project and aims to prove the economics of the historically producing mine and eventually position itself as the premier North American supplier of high-purity natural graphite for advanced technological applications. “RFLXF’s initial drilling program includes 3,500 total meters of drilling cored to an average depth of 130 meters. Targets for the drill program were identified using data gathered for the initial 43-101 technical report dated Jan. 31, 2023, and historical data from original mining operations,” reads a recent article. “Besides powering fuel cells,…

FridayJul 28, 2023 12:48 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has incorporated a new wholly owned subsidiary: Lexaria Nutraceutical Corp., or LEXX Nutra. According to the announcement, LEXX Nutra was established to support Lexaria’s overall strategy of maximizing the potential for its patented DehydraTECH(TM) technology in a variety of markets. The company issued an exclusive perpetual license to LEXX Nutra, giving the new subsidiary rights to utilize, or sublicense the use of, DehydraTECH in an array of ways, including creating consumer packaged goods (“CPG”) and/or intermediate ingredients composed of any molecule except those associated with nicotine or cannabis. LEXX Nutra…

FridayJul 28, 2023 12:31 pm

NetworkNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Unique NanoAb Pipeline to Target Large, Growing Markets

BiondVax (NASDAQ: BVXV) is an innovative biotechnology company focused on developing, manufacturing and commercializing potential blockbuster immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company is developing a pipeline of unique nanosized antibody (“NanoAb”) therapies addressing diseases underserved by current treatments with large, growing markets, including dermatological conditions such as psoriasis. “BiondVax is initially targeting IL-17 [the human immune system cytokine, which is implicated in several diseases] for the treatment of psoriasis, where the market for therapeutics is expected to reach $44 billion by 2031,” reads a recent article. “The company’s plan for the IL-17 nanobody…

FridayJul 28, 2023 11:47 am

NetworkNewsBreaks — POMETA Participates in WSU Tree Fruit Technology Field Day, Spotlighting Intelligent Crop Load Management System

POMETA, an Addium company, will be featuring its intelligent crop load management system at Washington State University’s (“WSU”) Tree Fruit Technology Field Day, which takes place today. According to the announcement, the event agenda includes an overview and update of the SCRI Precision Crop Load Management in Apple project, along with demonstrations of several vision-based commercial technologies that are designed to assist in crop-load management; POMETA is one of the technologies that will be spotlighted. Specifically, POMETA’s presentation is slated for 9 a.m. PT. POMETA offers the most sophisticated computer vision technology, including a data acquisition app (“POMViz”) that offers a simple…

FridayJul 28, 2023 11:05 am

NetworkNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Disruptive Solution Drives Engagement, Meaningful Interactions

Electronic Servitor Publication Network (OTCQB: XESP) is a market disruptor focused on connecting companies and target audiences to drive growth. “XESP’s managed service provides B2B clients with cutting-edge data analysis and intelligent technology to help them reach and connect with their target markets and audiences. XESP helps companies – and their products and services – connect by digitally engaging audiences with content and dialog that otherwise and ordinarily could only be done through direct contact by sales personnel. Their service provides around-the-clock company-consumer interactions, instead of just momentary and episodic contact… The company has developed the Digital Engagement Engine(TM), a…

ThursdayJul 27, 2023 1:58 pm

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking Holistic Approach to Reducing Accident Risk with Lidar Technology

Cepton (NASDAQ: CPTN), a lidar innovator, advances high-performance lidar technology currently being applied by leading global companies and governments to vehicles, smart infrastructure and more. “CPTN is dedicated to reducing accident risk through a holistic approach that integrates lidar into traffic systems, intersections, and ADAS-powered vehicles to improve safety for passengers and pedestrians. Through engagements with the world’s leading OEMs, CPTN is taking lidar mainstream by commercializing high-performance, ultra-compact lidar solutions for ADAS that seamlessly integrate into modern vehicle designs. The company is also advancing its Helius(R) Smart Lidar System, which combines its MMT(R) lidar technology with edge computing and…

ThursdayJul 27, 2023 12:40 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract Selected for Poster Presentation at 2023 SNO/ASCO CNS Cancer Conference

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its abstract was selected for in-person poster presentation at the 2023 SNO/ASCO CNS Cancer Conference taking place in San Francisco from Aug. 10-12, 2023. Sandra Silberman, MD, PhD, chief medical officer of CNS Pharmaceuticals, will present the abstract titled, “A randomized, controlled trial of Berubicin, a topoisomerase II poison that appears to cross the blood-brain barrier (‘BBB’), after first-line therapy for glioblastoma multiforme (‘GBM’): Preliminary Results.” Dr. Silberman’s…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks